584 related articles for article (PubMed ID: 11359699)
1. Sphingolipid perturbations as mechanisms for fumonisin carcinogenesis.
Riley RT; Enongene E; Voss KA; Norred WP; Meredith FI; Sharma RP; Spitsbergen J; Williams DE; Carlson DB; Merrill AH
Environ Health Perspect; 2001 May; 109 Suppl 2(Suppl 2):301-8. PubMed ID: 11359699
[TBL] [Abstract][Full Text] [Related]
2. Disruption of sphingolipid metabolism and stimulation of DNA synthesis by fumonisin B1. A molecular mechanism for carcinogenesis associated with Fusarium moniliforme.
Schroeder JJ; Crane HM; Xia J; Liotta DC; Merrill AH
J Biol Chem; 1994 Feb; 269(5):3475-81. PubMed ID: 8106389
[TBL] [Abstract][Full Text] [Related]
3. Early fumonisin B1 toxicity in relation to disrupted sphingolipid metabolism in male BALB/c mice.
Tsunoda M; Sharma RP; Riley RT
J Biochem Mol Toxicol; 1998; 12(5):281-9. PubMed ID: 9664234
[TBL] [Abstract][Full Text] [Related]
4. Elevated sphingoid bases and complex sphingolipid depletion as contributing factors in fumonisin-induced cytotoxicity.
Yoo HS; Norred WP; Showker J; Riley RT
Toxicol Appl Pharmacol; 1996 Jun; 138(2):211-8. PubMed ID: 8658522
[TBL] [Abstract][Full Text] [Related]
5. Mycotoxin-induced elevation of free sphingoid bases in precision-cut rat liver slices: specificity of the response and structure-activity relationships.
Norred WP; Plattner RD; Dombrink-Kurtzman MA; Meredith FI; Riley RT
Toxicol Appl Pharmacol; 1997 Nov; 147(1):63-70. PubMed ID: 9356308
[TBL] [Abstract][Full Text] [Related]
6. Induction of apoptosis by fumonisin B1 in HT29 cells is mediated by the accumulation of endogenous free sphingoid bases.
Schmelz EM; Dombrink-Kurtzman MA; Roberts PC; Kozutsumi Y; Kawasaki T; Merrill AH
Toxicol Appl Pharmacol; 1998 Feb; 148(2):252-60. PubMed ID: 9473533
[TBL] [Abstract][Full Text] [Related]
7. Sphingolipid metabolism: roles in signal transduction and disruption by fumonisins.
Merrill AH; Sullards MC; Wang E; Voss KA; Riley RT
Environ Health Perspect; 2001 May; 109 Suppl 2(Suppl 2):283-9. PubMed ID: 11359697
[TBL] [Abstract][Full Text] [Related]
8. Persistence and reversibility of the elevation in free sphingoid bases induced by fumonisin inhibition of ceramide synthase.
Enongene EN; Sharma RP; Bhandari N; Miller JD; Meredith FI; Voss KA; Riley RT
Toxicol Sci; 2002 Jun; 67(2):173-81. PubMed ID: 12011476
[TBL] [Abstract][Full Text] [Related]
9. Evidence for disruption of sphingolipid metabolism as a contributing factor in the toxicity and carcinogenicity of fumonisins.
Riley RT; Wang E; Schroeder JJ; Smith ER; Plattner RD; Abbas H; Yoo HS; Merrill AH
Nat Toxins; 1996; 4(1):3-15. PubMed ID: 8680751
[TBL] [Abstract][Full Text] [Related]
10. Fumonisin-induced tumor necrosis factor-alpha expression in a porcine kidney cell line is independent of sphingoid base accumulation induced by ceramide synthase inhibition.
He Q; Riley RT; Sharma RP
Toxicol Appl Pharmacol; 2001 Jul; 174(1):69-77. PubMed ID: 11437650
[TBL] [Abstract][Full Text] [Related]
11. Fumonisins and fumonisin analogs as inhibitors of ceramide synthase and inducers of apoptosis.
Desai K; Sullards MC; Allegood J; Wang E; Schmelz EM; Hartl M; Humpf HU; Liotta DC; Peng Q; Merrill AH
Biochim Biophys Acta; 2002 Dec; 1585(2-3):188-92. PubMed ID: 12531553
[TBL] [Abstract][Full Text] [Related]
12. Dietary fumonisin B1 induces disruption of sphingolipid metabolism in Sprague-Dawley rats: a new mechanism of nephrotoxicity.
Riley RT; Hinton DM; Chamberlain WJ; Bacon CW; Wang E; Merrill AH; Voss KA
J Nutr; 1994 Apr; 124(4):594-603. PubMed ID: 8145083
[TBL] [Abstract][Full Text] [Related]
13. Mechanism of action of sphingolipids and their metabolites in the toxicity of fumonisin B1.
Soriano JM; González L; Catalá AI
Prog Lipid Res; 2005 Nov; 44(6):345-56. PubMed ID: 16266752
[TBL] [Abstract][Full Text] [Related]
14. Fumonisin B1 inhibits sphingosine (sphinganine) N-acyltransferase and de novo sphingolipid biosynthesis in cultured neurons in situ.
Merrill AH; van Echten G; Wang E; Sandhoff K
J Biol Chem; 1993 Dec; 268(36):27299-306. PubMed ID: 8262970
[TBL] [Abstract][Full Text] [Related]
15. Sphingoid bases and their phosphates: transient activation and delayed repression of protein kinase C isoforms and their possible involvement in fumonisin B1 cytotoxicity.
Gopee NV; Sharma RP
Toxicology; 2003 May; 187(2-3):239-50. PubMed ID: 12699912
[TBL] [Abstract][Full Text] [Related]
16. Ceramide synthase inhibition by fumonisin B1 treatment activates sphingolipid-metabolizing systems in mouse liver.
He Q; Suzuki H; Sharma N; Sharma RP
Toxicol Sci; 2006 Dec; 94(2):388-97. PubMed ID: 16960033
[TBL] [Abstract][Full Text] [Related]
17. Ceramide synthase inhibition by fumonisins: a perfect storm of perturbed sphingolipid metabolism, signaling, and disease.
Riley RT; Merrill AH
J Lipid Res; 2019 Jul; 60(7):1183-1189. PubMed ID: 31048407
[TBL] [Abstract][Full Text] [Related]
18. Characterization of cell-cycle arrest by fumonisin B1 in CV-1 cells.
Ciacci-Zanella JR; Merrill AH; Wang E; Jones C
Food Chem Toxicol; 1998; 36(9-10):791-804. PubMed ID: 9737426
[TBL] [Abstract][Full Text] [Related]
19. Alteration of tissue and serum sphinganine to sphingosine ratio: an early biomarker of exposure to fumonisin-containing feeds in pigs.
Riley RT; An NH; Showker JL; Yoo HS; Norred WP; Chamberlain WJ; Wang E; Merrill AH; Motelin G; Beasley VR
Toxicol Appl Pharmacol; 1993 Jan; 118(1):105-12. PubMed ID: 8430417
[TBL] [Abstract][Full Text] [Related]
20. DNA damage in astrocytes exposed to fumonisin B1.
Galvano F; Campisi A; Russo A; Galvano G; Palumbo M; Renis M; Barcellona ML; Perez-Polo JR; Vanella A
Neurochem Res; 2002 Apr; 27(4):345-51. PubMed ID: 11958538
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
